Tag Archives: Persistent

OnabotulinumtoxinA Therapy May Reduce Frequency, Severity of New Daily Persistent Headache – Clinical Pain Advisor

January 15, 2019 Share this content: OnabotulinumtoxinA injections were typically administered at the clinic every 3 months. OnabotulinumtoxinA therapy may effectively reduce the frequency and severity of new daily persistent headache at 12 months, according to a small study published in Clinical Neuropharmacology. The investigators of this single-center, retrospective study sought to examine the effectiveness of… Read More »